Serum cytokeratin 19 fragment in advanced lung cancer: could we eventually have a serum tumor marker?

INTRODUCTION: Lung cancer is one of the most lethal malignancies; however, no serum marker has been routinely recommended until now. METHODS: This is a prospective case control study including two groups of patients: Group I—patients with advanced lung cancer and Group II—patients with benign lung d...

Descripción completa

Detalles Bibliográficos
Autores principales: Bastawisy, Ahmed El, azzouny, Mahmoud El, Mohammed, Gamal, allah, Ahmad Awad, Behiry, Eman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907401/
https://www.ncbi.nlm.nih.gov/pubmed/24567753
http://dx.doi.org/10.3332/ecancer.2014.394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907401/
https://www.ncbi.nlm.nih.gov/pubmed/24567753
http://dx.doi.org/10.3332/ecancer.2014.394

Ejemplares similares